• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

三乙酰竹桃霉素对甲基泼尼松龙消除的剂量及时间相关效应。

Dose- and time-related effect of troleandomycin on methylprednisolone elimination.

作者信息

Szefler S J, Brenner M, Jusko W J, Spector S L, Flesher K A, Ellis E F

出版信息

Clin Pharmacol Ther. 1982 Aug;32(2):166-71. doi: 10.1038/clpt.1982.143.

DOI:10.1038/clpt.1982.143
PMID:6980076
Abstract

Effects of varying doses of troleandomycin (TAO) on methylprednisolone disposition were examined in five steroid-dependent asthmatic patients. The characteristic reduction in methylprednisolone elimination in the presence of TAO after a 40 mg IV methylprednisolone was also present after methylprednisolone doses as low as 4 mg. In patients receiving continuous TAO on an every-other-day basis, inhibition of methylprednisolone elimination was impaired to a greater extent on the "day on" TAO than on the "day off" TAO Methylprednisolone elimination on the day off TAO was still slower than that before TAO, however, TAO on a multiple-dose schedule resulted in greater reduction of methylprednisolone elimination than after a single TAO dose. These results suggest that TAO induces immediate and continued inhibition of methylprednisolone disposition.

摘要

在五名类固醇依赖型哮喘患者中研究了不同剂量的醋竹桃霉素(TAO)对甲泼尼龙代谢的影响。静脉注射40mg甲泼尼龙后,在TAO存在的情况下甲泼尼龙消除的特征性降低在甲泼尼龙剂量低至4mg时也存在。在每隔一天接受持续TAO治疗的患者中,与“停药日”相比,“用药日”TAO对甲泼尼龙消除的抑制作用受到更大程度的损害。然而,停药日甲泼尼龙的消除仍然比TAO治疗前慢,多剂量给药方案的TAO比单次TAO剂量后导致甲泼尼龙消除的更大程度降低。这些结果表明,TAO可立即并持续抑制甲泼尼龙的代谢。

相似文献

1
Dose- and time-related effect of troleandomycin on methylprednisolone elimination.三乙酰竹桃霉素对甲基泼尼松龙消除的剂量及时间相关效应。
Clin Pharmacol Ther. 1982 Aug;32(2):166-71. doi: 10.1038/clpt.1982.143.
2
Steroid-specific and anticonvulsant interaction aspects of troleandomycin-steroid therapy.三乙酰竹桃霉素-类固醇疗法的类固醇特异性及抗惊厥相互作用方面
J Allergy Clin Immunol. 1982 May;69(5):455-60. doi: 10.1016/0091-6749(82)90121-x.
3
The effect of troleandomycin on methylprednisolone elimination.三乙酰竹桃霉素对甲泼尼龙消除的影响。
J Allergy Clin Immunol. 1980 Dec;66(6):447-51. doi: 10.1016/0091-6749(80)90004-4.
4
Effect of low-dose troleandomycin on glucocorticoid pharmacokinetics and airway hyperresponsiveness in severely asthmatic children.小剂量醋竹桃霉素对重度哮喘患儿糖皮质激素药代动力学及气道高反应性的影响
Ann Allergy. 1990 Jul;65(1):37-45.
5
The incidence of corticosteroid side effects in chronic steroid-dependent asthmatics on TAO (troleandomycin) and methylprednisolone.在长期依赖类固醇的哮喘患者中,使用醋竹桃霉素(TAO)和甲基强的松龙时皮质类固醇副作用的发生率。
Ann Allergy. 1989 Aug;63(2):110-1.
6
A double-blind study of troleandomycin and methylprednisolone in asthmatic subjects who require daily corticosteroids.一项针对需要每日使用皮质类固醇的哮喘患者的双盲研究,比较了曲安西龙和甲基强的松龙的疗效。
Am Rev Respir Dis. 1993 Feb;147(2):398-404. doi: 10.1164/ajrccm/147.2.398.
7
Troleandomycin effects on methylprednisolone and methylprednisone interconversion and disposition in the rabbit.
Eur J Drug Metab Pharmacokinet. 1987 Jan-Mar;12(1):50-7. doi: 10.1007/BF03189861.
8
Use of TAO without methylprednisolone in the treatment of severe asthma.在无甲泼尼龙情况下使用TAO治疗重度哮喘。
Chest. 1991 Sep;100(3):849-50. doi: 10.1378/chest.100.3.849.
9
An improved protocol for the use of troleandomycin (TAO) in the treatment of steroid-requiring asthma.
J Allergy Clin Immunol. 1986 Jul;78(1 Pt 1):36-43. doi: 10.1016/0091-6749(86)90112-0.
10
Troleandomycin in the treatment of difficult asthma.三乙酰竹桃霉素治疗难治性哮喘
J Allergy Clin Immunol. 1993 Nov;92(5):677-82. doi: 10.1016/0091-6749(93)90010-d.

引用本文的文献

1
Macrolides versus placebo for chronic asthma.大环内酯类药物与安慰剂治疗慢性哮喘的比较。
Cochrane Database Syst Rev. 2021 Nov 22;11(11):CD002997. doi: 10.1002/14651858.CD002997.pub5.
2
Macrolide immunomodulation of chronic respiratory diseases.大环内酯类药物对慢性呼吸系统疾病的免疫调节作用。
Curr Infect Dis Rep. 2007 Jan;9(1):7-13. doi: 10.1007/s11908-007-0016-1.
3
Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data.低剂量糖皮质激素治疗类风湿关节炎的安全性:已发表证据及前瞻性试验数据
Ann Rheum Dis. 2006 Mar;65(3):285-93. doi: 10.1136/ard.2005.038638. Epub 2005 Aug 17.
4
Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids.全身给药糖皮质激素的药代动力学和药效学。
Clin Pharmacokinet. 2005;44(1):61-98. doi: 10.2165/00003088-200544010-00003.
5
Pharmacokinetic aspects of treating infections in the intensive care unit: focus on drug interactions.重症监护病房感染治疗的药代动力学方面:聚焦于药物相互作用。
Clin Pharmacokinet. 2001;40(11):833-68. doi: 10.2165/00003088-200140110-00004.
6
Pharmacokinetic considerations in the treatment of inflammatory bowel disease.炎症性肠病治疗中的药代动力学考量
Clin Pharmacokinet. 2001;40(10):723-51. doi: 10.2165/00003088-200140100-00003.
7
Effect of itraconazole on the pharmacokinetics of prednisolone and methylprednisolone and cortisol secretion in healthy subjects.伊曲康唑对健康受试者中泼尼松龙、甲泼尼龙药代动力学及皮质醇分泌的影响。
Br J Clin Pharmacol. 2001 May;51(5):443-50. doi: 10.1046/j.1365-2125.2001.01372.x.
8
Corticosteroid sparing agents in asthma.哮喘中的糖皮质激素节省剂
Thorax. 1995 May;50(5):577-82. doi: 10.1136/thx.50.5.577.
9
Macrolide antibacterials. Drug interactions of clinical significance.大环内酯类抗菌药物。具有临床意义的药物相互作用。
Drug Saf. 1995 Aug;13(2):105-22. doi: 10.2165/00002018-199513020-00005.
10
Clinical pharmacology of asthma. Implications for treatment.哮喘的临床药理学。对治疗的启示。
Drugs. 1993 Nov;46(5):847-62. doi: 10.2165/00003495-199346050-00005.